Debt and Interest (Narrative) - Urica Offering (Details) - Urica $ / shares in Units, $ in Millions |
1 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
|
Jun. 27, 2024
shares
|
Dec. 27, 2022
USD ($)
$ / shares
shares
|
Feb. 28, 2023 |
Dec. 31, 2024
USD ($)
|
|
| Debt Instrument [Line Items] | ||||
| Interest expense | $ 0.1 | |||
| Percent of Outstanding Loan Principal Amount for Calculation of Repayment Change | 7.50% | |||
| 8% Cumulative Convertible Class B Preferred Offering | ||||
| Debt Instrument [Line Items] | ||||
| Dividend rate percentage | 8.00% | |||
| Stock offering, price per share | $ / shares | $ 25 | |||
| Stock offering, number of shares issued | shares | 135,494 | |||
| Stock offering, gross proceeds | $ 2.9 | |||
| Warrants, fair value | $ 0.1 | |||
| Common Stock Warrant | ||||
| Debt Instrument [Line Items] | ||||
| Class Of Warrant Or Right Value Of Securities Called By Warrants Or Rights | shares | 2,028,345 |
| X | ||||||||||
- Definition Value of securities into which the class of warrant or right may be converted. No definition available.
|
| X | ||||||||||
- Definition Percentage Of Outstanding Loan Principal Amount Prepayment Charge. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The percentage rate used to calculate dividend payments on preferred stock. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|